دورية أكاديمية
Combining atezolizumab 1200 mg with bevacizumab 15 mg/kg: based on science or just revenues?
| العنوان: | Combining atezolizumab 1200 mg with bevacizumab 15 mg/kg: based on science or just revenues? |
|---|---|
| المؤلفون: | Ratain, Mark J., Strohbehn, Garth W. |
| المصدر: | European Journal of Cancer ; volume 194, page 113349 ; ISSN 0959-8049 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2023 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Cancer Research, Oncology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.ejca.2023.113349 |
| الإتاحة: | https://doi.org/10.1016/j.ejca.2023.113349Test https://api.elsevier.com/content/article/PII:S0959804923006512?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0959804923006512?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; https://doi.org/10.15223/policy-017Test ; https://doi.org/10.15223/policy-037Test ; https://doi.org/10.15223/policy-012Test ; https://doi.org/10.15223/policy-029Test ; https://doi.org/10.15223/policy-004Test |
| رقم الانضمام: | edsbas.54FEB070 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.ejca.2023.113349 |
|---|